dr reddys labs
Dr. Reddy's Labs to launch Covid drug 2-DG at Rs 990 per sachet
The company will make the drug available in hospitals across metros and Tier 1 cities in the initial weeks
Dr Reddy's inks licensing pact with Gilead Sciences for Remdesivir
Gilead Sciences signed similar non-exclusive licensing agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan and Zydus Cadila
1 of 1